Non-Coding RNA Assays Market - Top Companies and Manufacturers

  • Report ID: 3730
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Companies Dominating the Non-Coding RNA Assays Landscape

    • Thermo Fisher Scientific Company
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Springer Nature Limited
    • Applied Microarrays Inc.
    • C D Genomics
    • RELX Group
    • MilliporeSigma
    • QIAGEN
    • Agilent Technologies, Inc.
    • Danaher Corporation
    • Eppendorf SE

Browse Key Market Insights with Data Illustration:

In the News

  • QIAGEN introduced QIAseq Targeted DNA Pro Panels and the QIAseq UPXome RNA Library Kit, to speed up the identification of DNA variants and RNA sequencing in low input samples. Further, the new solutions are based on enhanced chemistry that reduces the time required for library construction of DNA samples and establishes new criteria for processing materials in order to identify their nucleic acid sequences.

  • C D Genomics launched Whole Exome Sequencing, to extend its sequencing portfolio. Further, DNA sections known as exomes play a direct role in protein coding, and this approach is mostly employed to discover and investigate mutations in coding and UTR regions.


Author Credits:  Radhika Pawar


  • Report ID: 3730
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of non-coding rna assays is estimated at USD 304.19 Million.

The non-coding rna assays market size was valued at USD 269.08 Million in 2023 and is projected to cross USD 1.56 Billion by the end of 2036, expanding at more than 14.5% CAGR during the forecast period i.e., between 2024-2036. Growing prevalence of chronic diseases, and rising geriatric population are the major factors driving the market growth.

North America is anticipated to grow with the highest CAGR through 2036, attributed to availability of a large number of biotechnology and pharmaceutical companies.

Thermo Fisher Scientific Company, Springer Nature Limited, Applied Microarrays Inc., C D Genomics, RELX Group, MilliporeSigma, QIAGEN, Agilent Technologies, Inc., Danaher Corporation, Eppendorf SE
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample